Highlights and Quick Summary
- EBIT Margin for the quarter ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly EBIT Margin decreased by NaN%
- Annual EBIT Margin for 2021 was 0.0% (a NaN% decrease from previous year)
- Annual EBIT Margin for 2020 was 0.0% (a NaN% decrease from previous year)
- Annual EBIT Margin for 2019 was 0.0% (a NaN% decrease from previous year)
- Twelve month EBIT Margin ending September 30, 2022 was 0.0% (a NaN% decrease compared to previous quarter)
- Twelve month trailing EBIT Margin decreased by NaN% year-over-year
Trailing EBIT Margin for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| 0.0% | 0.0% | 0.0% | 0.0% |
Visit stockrow.com/BBLG
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical EBIT Margin of Bone Biologics Corp.
Most recent EBIT Marginof BBLG including historical data for past 10 years.Interactive Chart of EBIT Margin of Bone Biologics Corp.
Bone Biologics Corp. EBIT Margin for the past 10 Years (both Annual and Quarterly)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | 0.0% | 0.0% | 0.0% | – |
| 2021 | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| 2020 | – | – | – | – | 0.0% |
| 2019 | – | – | – | – | 0.0% |
| 2018 | – | – | – | – | 0.0% |
| 2017 | – | – | – | – | 0.0% |
Business Profile of Bone Biologics Corp.
Sector: Healthcare
Industry: Medical Devices